Market Closed -
Nasdaq
01:30:00 29/05/2024 am IST
5-day change
1st Jan Change
11.12
USD
+0.72%
-6.48%
-28.21%
Cryoport, Inc. completed the acquisition of Tec4Med Lifescience GmbH for ?3 million.
Cryoport, Inc. (NasdaqCM:CYRX) acquired Tec4Med Lifescience GmbH on November 2, 2023.
Cryoport, Inc. (NasdaqCM:CYRX) completed the acquisition of Tec4Med Lifescience GmbH for ?3 million on November 2, 2023.
Transcript : Cryoport, Inc., Q1 2024 Earnings Call, May 07, 2024
08/05
Earnings Flash (CYRX) CRYOPORT Posts Q1 Revenue $54.6M, vs. Street Est of $58.8M
08/05
MT
Cryoport, Inc. Reiterates Revenue Guidance for the Full Year 2024
08/05
CI
Cryoport, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
08/05
CI
North American Morning Briefing : Stock Futures -2-
06/05
DJ
B. Riley Downgrades Cryoport to Neutral From Buy, Adjusts Price Target to $19 From $22
03/05
MT
B. Riley Downgrades Cryoport to Neutral From Buy, Cuts Price Target to $19 From $22
03/05
MT
North American Morning Briefing : Investors on -2-
05/04
DJ
UBS Adjusts Cryoport Price Target to $17 From $14.50, Maintains Neutral Rating
15/03
MT
Tranche Update on Cryoport, Inc.'s Equity Buyback Plan announced on March 11, 2022.
14/03
CI
Needham Trims Price Target on Cryoport to $18 From $19, Keeps Buy Rating
13/03
MT
Transcript : Cryoport, Inc., Q4 2023 Earnings Call, Mar 12, 2024
13/03
Cryoport Q4 Net Loss Widens, Revenue Falls; Issues Guidance
13/03
MT
Earnings Flash (CYRX) CRYOPORT Posts Q4 Revenue $57.3M, vs. Street Est of $58.4M
13/03
MT
Cryoport, Inc. Announces Goodwill Impairment for the Quarter Ended December 31, 2023
13/03
CI
Cryoport, Inc. Provides Revenue Guidance for the Year 2024
13/03
CI
Cryoport, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
13/03
CI
What Alabama ruling means for patients with frozen embryos: one woman's story
24/02
RE
Cryoport, Inc. Announces Transition of Edward Zecchini from the Board of Directors to Sr. Vice President - Chief Digital & Technology Officer
16/02
CI
Needham Adjusts Cryoport's Price Target to $19 From $18, Maintains Buy Rating
19/01
MT
UBS Ups Price Target on Cryoport to $14.50 From $13.50, Maintains Neutral Rating
02/01
MT
Cryoport, Nippon Express Form Partnership to Offer Temperature-Controlled Supply Chain Services
28/11
MT
Cryoport, Inc. and Nippon EXPRESS HOLDINGS, Inc. Form Global Strategic Partnership for Temperature-Controlled Supply Chain Services
27/11
CI
Cryoport Acquires Bluebird Express
16/11
MT
Cryoport, Inc. acquired Bluebird Express LLC for $10.2 million.
16/11
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Cryoport, Inc. is engaged in supply chain solutions for cell and gene therapies. The Companyâs supply chain solutions enable manufacturers, contract manufacturers (CDMOâs), contract research organizations (CROâs), developers, and researchers to carry out their business with certainty. The Company provides a broad array of supply chain solutions for the life sciences industry. Through its platform of critical products and solutions, including advanced temperature-controlled packaging, informatics, specialized bio-logistics services, bio-storage, bio-services, and cryogenic systems, the Company is enabling the future of medicine worldwide, through its systems, compliant procedures, and approach to supply chain management. Its products and services include Cryoport Express Shippers, Cryoport ELITE Shipper Systems, Cryoport Consulting Services, Cryoport Bioservices, CRYOGENE, CRYOPDP Temperature-controlled Logistics, Cryoport Cryoshuttle, IntegriCell Services, Tec4Med, and others.
More about the company
Last Close Price
11.12
USD
Average target price
17.89
USD
Spread / Average Target
+60.87%
Consensus
1st Jan change
Capi.
-28.21% 548M -9.30% 7.06B +34.47% 5.58B +4.87% 3.69B +28.92% 2.65B +5.06% 976M -10.74% 608M -29.23% 508M -4.45% 473M -11.89% 430M
Freight Logistics
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1